drugset / Trial / NCT05017870
[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic characteristic of KSR-001.
Timeline
- Start
- 2018-12-02
- Primary completion
- 2019-06-14
- Completion
- 2020-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KSR-001 | Unknown | — | Other |
| Subject | KSR-001-02 | Unknown | — | — |
| Subject | KSR-001-03 | Unknown | — | — |